Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New radiotherapy strategy improves survival for lung cancer patients

02.06.2003


Study results presented at the 39th annual meeting for the American Society of Clinical Oncology (ASCO) by Chandra P. Belani, M.D., professor of medicine, University of Pittsburgh and co-director, Lung Cancer Program, University of Pittsburgh Cancer Institute (UPCI), demonstrate that a new therapeutic radiation strategy for non-small cell lung cancer (NSCLC) – the most common form of the disease – leads to improved survival for lung cancer patients with locally advanced disease.



n the study, hyperfractionated accelerated radiotherapy (HART) was compared to standard thoracic radiotherapy following chemotherapy. HART is a strategy in which radiation is administered frequently over a shorter period of time for two and a half weeks compared to seven weeks.

The phase III multi-site study compared HART to standard radiation therapy in 119 patients with unresectable stage III NSCLC. The patients were randomized into the two groups following two cycles of chemotherapy. Results indicated a median survival of 21 months for patients who received chemotherapy followed by HART, compared to a median survival of 12 months for patients who received chemotherapy followed by standard radiation therapy. One, two and three-year survival rates were 60 percent, 37 percent and 23 percent respectively in the HART group compared to one, two and three-year survival rates of 52 percent, 28 percent and 15 percent in the standard radiation therapy group.


"We found that chemotherapy followed by HART was an effective treatment strategy that was well tolerated by patients enrolled in the trial," said Dr. Belani, lead investigator of the study. "These data provide further verification that shortening the duration of radiation treatment may be an important therapeutic strategy for locally advanced NSCLC."

Non-small cell lung cancer is the most common type of lung cancer, accounting for almost 80 percent of lung cancers.



CONTACT:
Clare Collins
Jocelyn Uhl
PHONE: (412) 647-3555
FAX: (412) 624-3184
E-MAIL:
CollCX@upmc.edu
UhlJH@upmc.edu

Clare Collins | EurekAlert!
Further information:
http://www.upci.upmc.edu
http://www.upmc.edu/

More articles from Health and Medicine:

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

nachricht Study advances gene therapy for glaucoma
17.01.2018 | University of Wisconsin-Madison

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Polymers Based on Boron?

18.01.2018 | Life Sciences

Bioengineered soft microfibers improve T-cell production

18.01.2018 | Life Sciences

World’s oldest known oxygen oasis discovered

18.01.2018 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>